These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

445 related articles for article (PubMed ID: 19100234)

  • 1. [Hepatitis B in patients with HIV infection].
    Barreiro P; Martín-Carbonero L; García-Samaniego J
    Enferm Infecc Microbiol Clin; 2008 May; 26 Suppl 7():71-9. PubMed ID: 19100234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical management of patients with chronic hepatitis B virus infection].
    Rodríguez M; González-Diéguez ML
    Enferm Infecc Microbiol Clin; 2008 May; 26 Suppl 7():56-65. PubMed ID: 19100232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Nucleoside and nucleotide analogs in the treatment of chronic hepatitis B].
    Buti M
    Enferm Infecc Microbiol Clin; 2008 May; 26 Suppl 7():32-8. PubMed ID: 19100229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis B in HIV patients: what is the current treatment and what are the challenges?
    Soriano V; Tuma P; Vispo E; Labarga P; Fernández JV; Medrano J; Barreiro P
    J HIV Ther; 2009 Mar; 14(1):13-8. PubMed ID: 19731560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis B virus treatment in HIV-infected patients.
    Thio CL
    Top HIV Med; 2006 Dec-2007 Jan; 14(5):170-5. PubMed ID: 17237559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Long-term therapy for chronic hepatitis B in HIV co-infected patients].
    Pais R; Benhamou Y
    Gastroenterol Clin Biol; 2010 Sep; 34 Suppl 2():S136-41. PubMed ID: 21095517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Interferon in hepatitis B].
    García Buey L; González Mateos F; Moreno Otero R
    Enferm Infecc Microbiol Clin; 2008 May; 26 Suppl 7():19-31. PubMed ID: 19100228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-hepatitis B virus activity in vitro of combinations of tenofovir with nucleoside/nucleotide analogues.
    Zhu Y; Curtis M; Qi X; Miller MD; Borroto-Esoda K
    Antivir Chem Chemother; 2009; 19(4):165-76. PubMed ID: 19374144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Review article: current antiviral therapy of chronic hepatitis B.
    Ayoub WS; Keeffe EB
    Aliment Pharmacol Ther; 2008 Jul; 28(2):167-77. PubMed ID: 18466358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pharmacological agents for the treatment of chronic hepatitis B].
    Sánchez-Tapias JM
    Gastroenterol Hepatol; 2008 Mar; 31(3):120-8. PubMed ID: 18341843
    [No Abstract]   [Full Text] [Related]  

  • 11. HIV-HBV coinfection in Southern Africa and the effect of lamivudine- versus tenofovir-containing cART on HBV outcomes.
    Hamers RL; Zaaijer HL; Wallis CL; Siwale M; Ive P; Botes ME; Sigaloff KC; Hoepelman AI; Stevens WS; Rinke de Wit TF;
    J Acquir Immune Defic Syndr; 2013 Oct; 64(2):174-82. PubMed ID: 23892239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Resistance in hepatitis B virus].
    Sheldon J; Sarmento E Castro R; Soriano V
    Enferm Infecc Microbiol Clin; 2008 May; 26 Suppl 7():49-55. PubMed ID: 19100231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of human immunodeficiency virus on viral hepatitis.
    Mallet V; Vallet-Pichard A; Pol S
    Liver Int; 2011 Jan; 31 Suppl 1():135-9. PubMed ID: 21205151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacotherapy of hepatitis B infection: a brief review.
    Quan DJ
    Nephrol Nurs J; 2008; 35(5):507-10, 534. PubMed ID: 18856082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiretroviral therapy for hepatitis B virus-HIV-coinfected patients: promises and pitfalls.
    Levy V; Grant RM
    Clin Infect Dis; 2006 Oct; 43(7):904-10. PubMed ID: 16941375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drugs in development for hepatitis B.
    Buti M; Esteban R
    Drugs; 2005; 65(11):1451-60. PubMed ID: 16033287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Five-year on-treatment efficacy of lamivudine-, tenofovir- and tenofovir + emtricitabine-based HAART in HBV-HIV-coinfected patients.
    Kosi L; Reiberger T; Payer BA; Grabmeier-Pfistershammer K; Strassl R; Rieger A; Peck-Radosavljevic M
    J Viral Hepat; 2012 Nov; 19(11):801-10. PubMed ID: 23043387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of a 48-week pegylated interferon therapy in hepatitis B e antigen positive HIV-co-infected patients on cART including tenofovir: EMVIPEG study.
    Miailhes P; Maynard-Muet M; Lebossé F; Carrat F; Bouix C; Lascoux-Combe C; Sogni P; Rey D; Barthe Y; Pol S; Cacoub P; Zoulim F; Piroth L
    J Hepatol; 2014 Oct; 61(4):761-9. PubMed ID: 24882048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Entecavir].
    Calleja JL; Peñas B
    Enferm Infecc Microbiol Clin; 2008 May; 26 Suppl 7():39-48. PubMed ID: 19100230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term outcome of tenofovir disoproxil fumarate use against hepatitis B in an HIV-coinfected cohort.
    Alvarez-Uria G; Ratcliffe L; Vilar J
    HIV Med; 2009 May; 10(5):269-73. PubMed ID: 19210695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.